Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone Depot Follow-up in Schizophrenia or Schizoaffective Disorder
NCT00495118Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by Janssen Pharmaceutical. Started Oct 2001; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00495118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00495118.